UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Evaluation and management of edema in children

Author
Rudolph P Valentini, MD
Section Editor
Tej K Mattoo, MD, DCH, FRCP
Deputy Editor
Melanie S Kim, MD

INTRODUCTION

Edema is a clinical condition characterized by an increase in interstitial fluid volume and tissue swelling that can be either localized or generalized. Severe generalized edema is known as anasarca. More localized interstitial fluid collections include ascites and pleural effusions.

The diagnostic approach to edema is based upon a thoughtful approach to the pathogenesis of its formation. Once a diagnosis is established, specific treatment of the underlying disorder can be given. If specific therapy is not available, general treatment such as optimization of fluid management can be considered.

The evaluation and management of edema in children will be presented in this topic review. The pathogenesis and etiology of edema in children are discussed separately. (See "Pathophysiology and etiology of edema in children".)

CLINICAL MANIFESTATIONS AND EVALUATION

The goals of the evaluation of a child with edema include the following:

Determine the underlying pathophysiology, character of the edema (localized or generalized), and cause, as it will guide both evaluation and treatment (table 1). A more detailed discussion on the etiology based on the pathogenesis of the edema is presented separately. (See "Pathophysiology and etiology of edema in children".)

                      

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Tue Apr 19 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Brasitus TA. Protein-losing gastroenteropathy. In: Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, Sleisenger JS (Ed), WB Saunders, Philadelphia 1993. p.1027.
  2. Braamskamp MJ, Dolman KM, Tabbers MM. Clinical practice. Protein-losing enteropathy in children. Eur J Pediatr 2010; 169:1179.
  3. Lewis LG. End-stage liver disease and cirrhosis. In: Saunders Manual of Pediatric Practice, Finberg L (Ed), WB Saunders, Philadelphia 1998. p.521.
  4. Molinari AC, Saracco P, Cecinati V, et al. Venous thrombosis in children: an emerging issue. Blood Coagul Fibrinolysis 2011; 22:351.
  5. Kerlin BA, Haworth K, Smoyer WE. Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol 2014; 29:989.
  6. Rose BD, Post TW. Edematous states. In: Clinical Physiology of Acid-Base and Electrolyte Disorders, Rose BD, Post TW (Eds), McGraw-Hill, New York 2001. p.478.
  7. Schrier RW, Ecder T. Gibbs memorial lecture. Unifying hypothesis of body fluid volume regulation: implications for cardiac failure and cirrhosis. Mt Sinai J Med 2001; 68:350.
  8. Zavagli G, Ricci G, Bader G, et al. The importance of the highest normokalemia in the treatment of early hepatic encephalopathy. Miner Electrolyte Metab 1993; 19:362.
  9. Sullivan MJ 3rd, Hough DR, Agodoa LC. Peripheral arterial thrombosis due to the nephrotic syndrome: the clinical spectrum. South Med J 1983; 76:1011.
  10. Hogg RJ, Portman RJ, Milliner D, et al. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 2000; 105:1242.
  11. Ginès P, Guevara M, De Las Heras D, Arroyo V. Review article: albumin for circulatory support in patients with cirrhosis. Aliment Pharmacol Ther 2002; 16 Suppl 5:24.
  12. Garcia-Martinez R, Caraceni P, Bernardi M, et al. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 2013; 58:1836.
  13. Niaudet P. Steriod-sensitive idiopathic nephrotic syndrome in children. In: Pediatric Nephrology, 5th ed, Avner ED, Harmon WE, Niaudet P (Eds), Lippincott Williams & Wilkins, Philadelphia 2004. p.549.
  14. Greissman A, Silver P, Nimkoff L, Sagy M. Albumin bolus administration versus continuous infusion in critically ill hypoalbuminemic pediatric patients. Intensive Care Med 1996; 22:495.